Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Capital Employed (2024 - 2025)

Historic Return on Capital Employed for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 0.36%.

  • Day One Biopharmaceuticals' Return on Capital Employed rose 1000.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.54% for FY2024, which is 800.0% up from last year.
  • Day One Biopharmaceuticals' Return on Capital Employed amounted to 0.36% in Q3 2025, which was up 1000.0% from 0.24% recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Return on Capital Employed registered a high of 0.24% during Q2 2025, and its lowest value of 1.08% during Q2 2024.